Episodic migraine Trials in Cincinnati, United States
Conditions / Episodic migraine / Cincinnati, United States
Clinical trials for Episodic migraine investigate a range of treatment strategies and patient populations.
14 total trials for this combination
Showing top 10 of 14 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04740827 | Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments. | COMPLETED | PHASE3 |
| NCT03432286 | A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03777059 | 12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine | COMPLETED | PHASE3 |
| NCT03700320 | Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine | COMPLETED | PHASE3 |
| NCT04686136 | A Long-Term Safety and Tolerability Extension Study Evaluating Atogepant for the Prevention of Chronic or Episodic Migraine | COMPLETED | PHASE3 |
| NCT05028569 | Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic Migraine | TERMINATED | PHASE3 |
| NCT07018700 | A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine | RECRUITING | — |
| NCT06625060 | A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults | RECRUITING | PHASE2 |
| NCT03939312 | Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine | COMPLETED | PHASE3 |
| NCT06047457 | A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults | ACTIVE_NOT_RECRUITING | — |